A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19
<p><strong>Background</strong> No therapeutics have yet been proven effective for the treatment of severe illness caused by SARS-CoV-2.</p> <p><strong>Methods</strong> We conducted a randomized, controlled, open-label trial involving hospitalized adult pati...
Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
Massachusetts Medical Society
2020
|